story of the week
Interferon Alpha vs Hydroxyurea in Patients With Polycythemia Vera and Essential Thrombocythemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia
Blood 2022 May 12;139(19)2931-2941, J Mascarenhas, HE Kosiorek, JT Prchal, A Rambaldi, D Berenzon, A Yacoub, CN Harrison, MF McMullin, AM Vannucchi, J Ewing, CL O'Connell, JJ Kiladjian, AJ Mead, EF Winton, DS Leibowitz, V De Stefano, MO Arcasoy, CM Kessler, R Catchatourian, D Rondelli, RT Silver, A Bacigalupo, A Nagler, M Kremyanskaya, MF Levine, JE Arango Ossa, E McGovern, L Sandy, ME Salama, V Najfeld, J Tripodi, N Farnoud, AV Penson, RS Weinberg, L Price, JD Goldberg, T Barbui, R Marchioli, G Tognoni, RK Rampal, RA Mesa, AC Dueck, R HoffmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.